Allergan considers options for women’s health unit: Bloomberg

Allergan Plc is considering options for its women’s health unit and has held talks with advisers, Bloomberg said. Strategic options for the unit include a sale, which could value the business at more than $5 billion, the story said. A sale would likely attract private equity firms, although Allergan has not decided to pursue a sale of the business and could elect to keep it, Bloomberg said.